Bruker BioSciences Corporation

Biotech company appoints William Knight as chief financial officer

Published in Health Business Week, November 12th, 2004

Bruker BioSciences Corporation (BRKR) announced that William J. Knight has been appointed as its new chief financial officer, effective as of October 25, 2004, and based in Massachusetts.

Knight has 8 years of experience as a chief financial officer in the biotechnology and medical device industries, and nearly 30 years of experience in senior financial management and public accounting, including 16 years with international manufacturers of scientific instruments.

Knight was most recently chief financial officer of Anika Therapeutics, Inc., a publicly traded medical device company located in Woburn, Massachusetts. Previously, Knight served as chief...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-11-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry